These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16277609)

  • 1. Altered glycosylation of acetylcholinesterase in Creutzfeldt-Jakob disease.
    Silveyra MX; Cuadrado-Corrales N; Marcos A; Barquero MS; Rábano A; Calero M; Sáez-Valero J
    J Neurochem; 2006 Jan; 96(1):97-104. PubMed ID: 16277609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered glycosylation of acetylcholinesterase in the Creutzfeldt-Jakob cerebrospinal fluid.
    Silveyra MX; García-Ayllón MS; Calero M; Sáez-Valero J
    J Mol Neurosci; 2006; 30(1-2):65-6. PubMed ID: 17192630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of water channel aquaporin 1 and aquaporin 4 in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP transgenic mice.
    Rodríguez A; Pérez-Gracia E; Espinosa JC; Pumarola M; Torres JM; Ferrer I
    Acta Neuropathol; 2006 Nov; 112(5):573-85. PubMed ID: 16871401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrovascular P-glycoprotein expression is decreased in Creutzfeldt-Jakob disease.
    Vogelgesang S; Glatzel M; Walker LC; Kroemer HK; Aguzzi A; Warzok RW
    Acta Neuropathol; 2006 May; 111(5):436-43. PubMed ID: 16523342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between acetylcholinesterase and beta-amyloid peptide in Alzheimer's cerebrospinal fluid.
    García-Ayllón MS; Silveyra MX; Sáez-Valero J
    Chem Biol Interact; 2008 Sep; 175(1-3):209-15. PubMed ID: 18554581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP mice.
    Rodríguez A; Martín M; Albasanz JL; Barrachina M; Espinosa JC; Torres JM; Ferrer I
    J Neuropathol Exp Neurol; 2006 Oct; 65(10):964-75. PubMed ID: 17021401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activities and concentrations in patients with sporadic Creutzfeldt-Jakob disease.
    Zerr I; Bodemer M; Kaboth U; Kretzschmar H; Oellerich M; Armstrong VW
    Neurosci Lett; 2004 Nov; 371(2-3):163-6. PubMed ID: 15519749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial EEG findings in sporadic and iatrogenic Creutzfeldt-Jakob disease.
    Wieser HG; Schwarz U; Blättler T; Bernoulli C; Sitzler M; Stoeck K; Glatzel M
    Clin Neurophysiol; 2004 Nov; 115(11):2467-78. PubMed ID: 15465434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safe method for isolation of prion protein and diagnosis of Creutzfeldt-Jakob disease.
    Bastian FO; McDermott ME; Perry AS; Carver LA; Dash S; Garry RF
    J Virol Methods; 2005 Dec; 130(1-2):133-9. PubMed ID: 16102852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of 14-3-3 proteins in reactive astrocytes in Creutzfeldt-Jakob disease brains.
    Kawamoto Y; Akiguchi I; Jarius C; Budka H
    Acta Neuropathol; 2004 Oct; 108(4):302-8. PubMed ID: 15235801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid acetylcholinesterase activity in senile dementia of the Alzheimer type.
    Tune L; Gucker S; Folstein M; Oshida L; Coyle JT
    Ann Neurol; 1985 Jan; 17(1):46-8. PubMed ID: 3985585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases.
    Steinacker P; Mollenhauer B; Bibl M; Cepek L; Esselmann H; Brechlin P; Lewczuk P; Poser S; Kretzschmar HA; Wiltfang J; Trenkwalder C; Otto M
    Neurosci Lett; 2004 Nov; 370(1):36-9. PubMed ID: 15489013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease.
    Sáez-Valero J; Sberna G; McLean CA; Small DH
    J Neurochem; 1999 Apr; 72(4):1600-8. PubMed ID: 10098867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion deposition in olfactory biopsy of sporadic Creutzfeldt-Jakob disease.
    Tabaton M; Monaco S; Cordone MP; Colucci M; Giaccone G; Tagliavini F; Zanusso G
    Ann Neurol; 2004 Feb; 55(2):294-6. PubMed ID: 14755736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.
    Buerger K; Otto M; Teipel SJ; Zinkowski R; Blennow K; DeBernardis J; Kerkman D; Schröder J; Schönknecht P; Cepek L; McCulloch C; Möller HJ; Wiltfang J; Kretzschmar H; Hampel H
    Neurobiol Aging; 2006 Jan; 27(1):10-5. PubMed ID: 16298235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid acetylcholinesterase changes after treatment with donepezil in patients with Alzheimer's disease.
    García-Ayllón MS; Silveyra MX; Andreasen N; Brimijoin S; Blennow K; Sáez-Valero J
    J Neurochem; 2007 Jun; 101(6):1701-11. PubMed ID: 17326766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada.
    Ladogana A; Puopolo M; Croes EA; Budka H; Jarius C; Collins S; Klug GM; Sutcliffe T; Giulivi A; Alperovitch A; Delasnerie-Laupretre N; Brandel JP; Poser S; Kretzschmar H; Rietveld I; Mitrova E; Cuesta Jde P; Martinez-Martin P; Glatzel M; Aguzzi A; Knight R; Ward H; Pocchiari M; van Duijn CM; Will RG; Zerr I
    Neurology; 2005 May; 64(9):1586-91. PubMed ID: 15883321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Prion protein expression pattern in CSF as a biomarker for Creutzfeldt-Jakob disease.
    Torres M; Cartier L; Matamala JM; Hernández N; Woehlbier U; Hetz C
    PLoS One; 2012; 7(4):e36159. PubMed ID: 22558368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nigrostriatal pathway in Creutzfeldt-Jakob disease.
    Vital A; Fernagut PO; Canron MH; Joux J; Bezard E; Martin-Negrier ML; Vital C; Tison F
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):809-15. PubMed ID: 19535991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of a test of cellular fusion in Creutzfeldt-Jakob and Alzheimer diseases (author's transl)].
    Moreau-Dubois MC; Cathala F; Brown P; Gajdusek DC
    Rev Neurol (Paris); 1980; 136(5):401-9. PubMed ID: 7008140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.